BPA for kyzatrex
Active Awarded Last action
- Contract number
- 36E79724A0009
- Awardee
-
Marius Pharmaceuticals, Inc. UEI XJP7M618A5Q8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 87% complete
- IDV ceiling
- $1,406.70
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) was awarded as a single award by the National Acquisition Center, the procurement entity for the Department of Veterans Affairs (VA), to Marius Pharmaceuticals, Inc., a small disadvantaged business, for the supply of KYZATREX, a pharmaceutical product. The BPA was awarded on March 13, 2024, with a ceiling value of $1,406.70 and an ultimate completion date of March 12, 2027, representing the second option year exercise under the master BPA vehicle 36E79724A0009. No set-aside category was applied to this award. The contract is organized under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which establishes the pricing and terms for pharmaceutical procurement across the VA health system.
The BPA mechanism streamlines the ordering process for VA medical centers nationwide to procure KYZATREX for veteran patients without requiring individual competitive solicitations for each order. Marius Pharmaceuticals holds multiple federal contract vehicles with the VA, including this series of BPAs and a separate FSS contract with a maximum potential value of $2.25 million through January 31, 2029, reflecting the company's established role as a pharmaceutical supplier to VA facilities. KYZATREX is utilized within VA Veterans Health Administration treatment programs, and the BPA structure enables expedited access to this pharmaceutical product across the VA's medical facility network. The relatively modest ceiling value of this particular option year reflects the specific ordering demand for this fiscal period, while the larger master BPA vehicle accommodates aggregate ordering capacity across the extended performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0009?
36E79724A0009 was awarded to Marius Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on March 13, 2024.
How much is contract 36E79724A0009 worth?
36E79724A0009's own ceiling is $1,407.
Who can order from contract 36E79724A0009?
36E79724A0009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0009 under another contract?
Yes. 36E79724A0009 is a blanket purchase agreement under 36F79724D0059, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0009 competed?
The extent of competition for 36E79724A0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV